Goldman Sachs’s Avanos Medical AVNS Stock Holding History

Goldman Sachs’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-50,000	Closed	-$2.86M	–	5555
2018 Q2	$2.86M	Buy	+50,000	New	+$2.64M	﹤0.01%	3362
2017 Q1	–	Sell	-1,380	Closed	-$51K	–	6742
2016 Q4	$51K	Hold	1,380	–	–	﹤0.01%	6381
2016 Q3	$48K	Hold	1,380	–	–	﹤0.01%	6485
2016 Q2	$45K	Sell	1,380 -50,000	-97%	-$1.53M	﹤0.01%	6459
2016 Q1	$1.48M	Sell	51,380 -1,224	-2%	-$32.6K	﹤0.01%	3749
2015 Q4	$1.76M	Buy	52,604 +49,988	+1,911%	+$1.55M	﹤0.01%	3756
2015 Q3	$74K	Sell	2,616 -120	-4%	-$4.19K	﹤0.01%	6636
2015 Q2	$111K	Sell	2,736 -1,380	-34%	-$61.9K	﹤0.01%	6554
2015 Q1	$203K	Sell	4,116 -7,032	-63%	-$326K	﹤0.01%	6007
2014 Q4	$507K	Buy	+11,148	New	+$438K	﹤0.01%	5265

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Goldman Sachs's AVNS Position: Q2 2026 in Review

Goldman Sachs increased its Avanos Medical (AVNS) stake by 59% in Q2 2026, buying an estimated $6.66M and bringing the position to 765,416 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #2680.

Goldman Sachs first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $99M in Q3 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Goldman Sachs held 765,416 shares of Avanos Medical worth $19M as of Q2 2026.
Goldman Sachs bought 284,530 Avanos Medical shares in Q2 2026, an estimated $6.66M.
Avanos Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2680 holding.
Goldman Sachs first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
Goldman Sachs's Avanos Medical position peaked at $99M in Q3 2018.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.